Glecaprevir

Description

Glecaprevir · CAS 1365970-03-1 · C38H46F4N6O9S. UNII K6BUU8J72P. Solubility: <0.1 to 0.3 mg/mL.

Identification

Computed Descriptors

Physical & Chemical Properties

Documented Uses

• Indicated for the treatment of adult patients with acute and chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult patients with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.
• Breast Feeding; Lactation; Milk, Human; Antiviral Agents; Protease Inhibitors
• Avoid St. John's Wort. Co-administration may lead to decreased serum concentrations of glecaprevir.
• Established Pharmacologic Class [EPC] - Hepatitis C Virus NS3/4A Protease Inhibitor
• Mechanisms of Action [MoA] - HCV NS3/4A Protease Inhibitors
• Mechanisms of Action [MoA] - P-Glycoprotein Inhibitors

Synonyms

Glecaprevir; 1365970-03-1; ABT-493; Maviret; K6BUU8J72P; A-1282576.0; A-1282576; A-12825760; DTXSID901027945; glecaprevirum; RefChem:663069; DTXCID101513512; Glecaprevir [USAN]; BDBM50573891; UNII-K6BUU8J72P; MFCD30533436

Frequently Asked Questions

What are the CAS number and molecular formula of Glecaprevir?

CAS 1365970-03-1; molecular formula C38H46F4N6O9S; molecular weight — g/mol.

What other names is Glecaprevir known by?

Glecaprevir, 1365970-03-1, ABT-493, Maviret, K6BUU8J72P, A-1282576.0.

What are the key physical properties of Glecaprevir?

Solubility: <0.1 to 0.3 mg/mL.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.